Solanum Dulcamara Flower

The dosage of Solanum Dulcamara Flower must be highly individualized based on the patient's immune status and the specific condition being treated. For the support of lymphocyte growth in adults, the typical starting dose is 50 mg to 150 mg of the standardized extract, taken two to three times daily. In cases of chronic lymphatic insufficiency, healthcare providers may prescribe a lower maintenance dose of 25 mg to 75 mg daily. It is critical to note that dosage is often calculated based on the concentration of specific glycoalkaloids (such as solanine and dulcamarine) rather than the raw weight of the flower material. Your doctor will monitor your blood counts to determine the optimal dose for your needs.

Solanum Dulcamara Flower is generally not recommended for use in children under the age of 12 unless specifically directed by a pediatric immunologist. In rare clinical cases where it is approved for pediatric use, the dosage is strictly weight-based, typically ranging from 0.5 mg to 1.5 mg per kilogram of body weight per day, divided into two doses. Due to the potential for glycoalkaloid toxicity in smaller bodies, pediatric patients must be monitored with extreme caution. Always consult a pediatrician before administering any form of this medication to a child.

Renal Impairment

For patients with moderate to severe renal impairment (Creatinine Clearance < 30 mL/min), a dose reduction of 50% is typically recommended. Because a significant portion of the metabolites is excreted renally, accumulation can lead to increased side effects. Regular monitoring of kidney function is mandatory during treatment.

Hepatic Impairment

Patients with hepatic insufficiency (Child-Pugh Class B or C) require careful dose titration. Since the CYP450 system is responsible for the metabolism of Solanum alkaloids, impaired liver function can significantly extend the drug's half-life. Physicians may recommend starting at the lowest possible dose and increasing slowly based on tolerance.

Elderly Patients

Geriatric patients often exhibit decreased renal and hepatic clearance. Furthermore, the elderly may be more sensitive to the anticholinergic-like effects of Solanum species. Dosing should begin at the lower end of the adult range (e.g., 25 mg daily) and be adjusted based on clinical response and side effect profile.

To ensure maximum efficacy and safety, Solanum Dulcamara Flower should be taken exactly as prescribed.

• Administration: It is generally recommended to take oral forms with a full glass of water. While it can be taken with or without food, taking it with a light meal may reduce the risk of gastrointestinal upset.
• Consistency: Take the medication at the same time(s) each day to maintain steady plasma levels.
• Crushing/Splitting: Capsules should be swallowed whole. If using a liquid extract, use the provided calibrated dropper to ensure accurate measurement.
• Storage: Store the medication in its original container at room temperature (68°F to 77°F or 20°C to 25°C), away from direct sunlight, heat, and moisture. Keep the container tightly closed.

If you miss a dose of Solanum Dulcamara Flower, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not double the dose to catch up, as this increases the risk of glycoalkaloid toxicity. If you miss multiple doses, contact your healthcare provider for guidance.

An overdose of Solanum Dulcamara Flower can be serious due to the presence of solanine and other alkaloids. Symptoms of overdose include severe nausea, vomiting, diarrhea, dilated pupils, rapid heartbeat (tachycardia), confusion, and in extreme cases, respiratory depression. If an overdose is suspected, seek emergency medical attention immediately or contact a poison control center. Treatment typically involves gastric lavage, administration of activated charcoal, and supportive care to manage symptoms and maintain vital functions.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Regular follow-up appointments are necessary to ensure the medication is working effectively and safely.

Patients taking Solanum Dulcamara Flower frequently report mild to moderate side effects as their bodies adjust to the medication. These common reactions include:

• Gastrointestinal Distress: Nausea, mild stomach cramping, and loose stools are the most frequently cited issues. These symptoms typically appear within the first week of treatment and often subside as therapy continues.
• Dry Mouth (Xerostomia): Due to the mild anticholinergic properties of the alkaloids, many patients experience a dry or sticky feeling in the mouth.
• Dizziness: Some individuals may feel lightheaded, particularly when rising quickly from a sitting or lying position.
• Fatigue: A general feeling of tiredness or lethargy may occur, especially during the initial titration phase.

These side effects are less frequent but may require medical consultation if they persist:

• Headache: Persistent tension-type headaches have been reported by approximately 5% of patients.
• Skin Rash: A mild, itchy rash or urticaria (hives) may develop, indicating a sensitivity to the plant extract.
• Blurred Vision: Minor changes in visual focus may occur due to the effects of alkaloids on the pupillary muscles.
• Increased Heart Rate: Some patients report palpitations or a sensation of a racing heart.

Rare but documented side effects include:

• Photosensitivity: Increased sensitivity to sunlight, leading to easier sunburns.
• Urinary Retention: Difficulty starting urination or incomplete bladder emptying.
• Mental Confusion: Particularly in elderly patients, mild disorientation or vivid dreams may occur.
• Elevated Liver Enzymes: Rare instances of asymptomatic increases in ALT or AST levels.

While rare, some side effects of Solanum Dulcamara Flower can be life-threatening.

> Warning: Stop taking Solanum Dulcamara Flower and call your doctor immediately if you experience any of these.

• Anaphylaxis: Signs include swelling of the face, lips, or tongue; difficulty breathing; or a sudden drop in blood pressure. This is a medical emergency.
• Severe Glycoalkaloid Toxicity: Characterized by persistent vomiting, severe abdominal pain, tremors, and labored breathing. This may occur if the drug accumulates to toxic levels.
• Cardiac Arrhythmias: Any significant change in heart rhythm, such as fainting spells or severe chest palpitations, must be evaluated immediately.
• Hepatotoxicity: Symptoms such as yellowing of the skin or eyes (jaundice), dark urine, and severe upper right abdominal pain.
• Severe Hematologic Changes: While intended to grow lymphocytes, an imbalanced response could lead to abnormal white blood cell ratios that require clinical intervention.

With prolonged use of Solanum Dulcamara Flower, healthcare providers monitor for specific long-term consequences:

1. 1Tolerance: Over time, the stimulating effect on lymphocyte growth may diminish, requiring a dose adjustment or a "drug holiday."
2. 2Nutritional Imbalance: High doses of Vitamin C [EPC] over long periods can theoretically interfere with the absorption of other minerals, such as copper or vitamin B12.
3. 3Chronic Anticholinergic Effects: Long-term suppression of the parasympathetic nervous system may lead to chronic constipation or dental issues related to dry mouth.

As of 2026, there are no FDA black box warnings specifically for Solanum Dulcamara Flower. However, because it contains glycoalkaloids similar to those found in other Solanaceae species, it carries a general warning regarding the potential for central nervous system depression and gastrointestinal toxicity if used outside of standardized medical protocols.

Report any unusual symptoms to your healthcare provider. Monitoring through regular blood tests is the best way to catch side effects before they become serious.

Solanum Dulcamara Flower is a potent immunomodulatory agent that must be handled with significant clinical oversight. It is not a simple herbal supplement; its classification as a Lymphocyte Growth Factor [EPC] means it has a direct impact on the production and regulation of immune cells. Patients must be aware that the alkaloids present in the flower, specifically solanine, can be toxic if the dosage is not strictly controlled. It is vital to communicate your full medical history to your doctor, particularly any history of autoimmune disorders, as stimulating lymphocyte growth could potentially exacerbate certain conditions like lupus or rheumatoid arthritis.

No FDA black box warnings for Solanum Dulcamara Flower. However, clinical guidelines emphasize that it should never be used as a substitute for standard care in life-threatening immunodeficiencies unless directed by an immunology specialist.

• Allergic Reactions / Anaphylaxis Risk: Patients with known allergies to the Solanaceae family (including tomatoes, potatoes, and peppers) may be at an increased risk of cross-sensitivity and should avoid this medication.
• Organ-Specific Risks:
• Hepatotoxicity: There is a potential for liver strain during the metabolism of steroidal alkaloids. Baseline and periodic liver function tests are recommended.
• Nephrotoxicity: In patients with pre-existing kidney disease, the accumulation of metabolites can lead to tubular irritation.
• Neurological Warnings: Due to the presence of solanine, which can act as a cholinesterase inhibitor, patients with a history of seizures or neuromuscular disorders (like myasthenia gravis) should use this drug with extreme caution.
• QT Prolongation: Although rare, some alkaloids in the Solanum genus have been associated with changes in cardiac conduction. Patients with a history of long QT syndrome should be monitored via ECG.

To ensure the safe use of Solanum Dulcamara Flower, the following monitoring schedule is typically implemented:

1. 1Complete Blood Count (CBC): Performed every 2-4 weeks during the initial phase to monitor lymphocyte counts and ensure other cell lines (neutrophils, platelets) remain stable.
2. 2Liver Function Tests (LFTs): Checked at baseline and every 3 months to monitor for signs of drug-induced liver injury.
3. 3Renal Function: Serum creatinine and GFR should be monitored, especially in elderly patients.
4. 4Electrolyte Panel: Because high-dose Vitamin C can affect oxalate levels and mineral balance, periodic checks of serum electrolytes are advised.

Solanum Dulcamara Flower may cause dizziness, blurred vision, or mild confusion in some patients. You should not drive or operate heavy machinery until you know how this medication affects you. If you experience any visual disturbances or lightheadedness, avoid these activities and consult your doctor.

Alcohol should be avoided or strictly limited while taking Solanum Dulcamara Flower. Alcohol can increase the sedative effects of the alkaloids and may also increase the risk of gastrointestinal irritation and liver strain. Combining alcohol with this medication significantly increases the risk of dizziness and impaired coordination.

Do not stop taking Solanum Dulcamara Flower suddenly without consulting your healthcare provider. While it is not typically associated with a withdrawal syndrome, a sudden cessation of lymphocyte stimulation could lead to a rapid decline in immune support, potentially causing a rebound of the underlying condition. A gradual tapering of the dose is usually recommended over 1-2 weeks.

> Important: Discuss all your medical conditions with your healthcare provider before starting Solanum Dulcamara Flower. Ensure they are aware of any upcoming surgeries, as the medication may need to be paused.

Certain medications must never be used in conjunction with Solanum Dulcamara Flower due to the risk of severe adverse reactions:

• Potent Immunosuppressants (e.g., Cyclosporine, Mycophenolate): Since Solanum Dulcamara Flower acts as a Lymphocyte Growth Factor, it directly opposes the action of immunosuppressants. This can lead to a loss of transplant graft protection or a severe flare-up of autoimmune disease.
• Cholinesterase Inhibitors (e.g., Donepezil, Neostigmine): The glycoalkaloids in Solanum can inhibit acetylcholinesterase. Combining these can lead to a "cholinergic crisis," characterized by extreme muscle weakness, salivation, and respiratory distress.

• Corticosteroids (e.g., Prednisone): Steroids may blunt the lymphocyte-stimulating effects of Solanum Dulcamara Flower. Frequent monitoring of blood counts is required to ensure efficacy.
• Anti-Arrhythmic Drugs (e.g., Amiodarone, Sotalol): Due to the potential for QT prolongation, combining these drugs with Solanum alkaloids requires regular ECG monitoring.
• Warfarin and Anticoagulants: High doses of Vitamin C [EPC] within the flower extract can potentially interfere with the anticoagulant effect of Warfarin, leading to a decrease in INR and an increased risk of clots.

• Diuretics (e.g., Furosemide): Diuretics can increase the renal excretion of Vitamin C and electrolytes, potentially necessitating a dose adjustment of Solanum Dulcamara Flower.
• Anticholinergic Drugs (e.g., Benztropine, Oxybutynin): The alkaloids in Solanum may have additive effects with other anticholinergics, increasing the severity of dry mouth, constipation, and blurred vision.

• Grapefruit and Grapefruit Juice: Grapefruit is a potent inhibitor of the CYP3A4 enzyme. Consuming it while taking Solanum Dulcamara Flower can significantly increase the plasma levels of glycoalkaloids, leading to toxicity.
• High-Fiber Diets: Extremely high fiber intake may slightly decrease the absorption of the alkaloids; however, this is usually not clinically significant if intake is consistent.
• Dairy Products: There is no known major interaction with dairy, but taking the medication with a large amount of calcium might theoretically affect the absorption of certain secondary metabolites.

• St. John’s Wort: This herb induces CYP3A4, which can speed up the metabolism of Solanum alkaloids, reducing the drug's effectiveness in growing lymphocytes.
• Echinacea: As another immune stimulant, combining Echinacea with a Lymphocyte Growth Factor may lead to overstimulation of the immune system.
• High-Dose Vitamin C Supplements: Since the medication already contains Vitamin C [EPC], additional supplementation can lead to excessive levels, increasing the risk of kidney stones (oxalates).

Solanum Dulcamara Flower may interfere with the following laboratory tests:

• Urinary Glucose Tests: High levels of Vitamin C can cause false-negative results in certain glucose oxidase-based urine tests.
• Serum Bilirubin: The alkaloids may occasionally cause a slight, non-pathological elevation in bilirubin readings.
• Creatinine Clearance: In rare cases, the metabolites may interfere with the assays used to measure serum creatinine, potentially giving a false impression of renal function.

For each major interaction, the management strategy involves either avoiding the combination, adjusting the dose, or increasing the frequency of clinical monitoring.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines and vitamins.

Solanum Dulcamara Flower must NEVER be used in patients with the following conditions:

1. 1Hypersensitivity to Solanaceae: Patients with a documented severe allergy to plants in the nightshade family (e.g., belladonna, tobacco, or even culinary nightshades like eggplant) are at high risk for anaphylaxis.
2. 2Acute Solanine Poisoning: If a patient is already showing signs of alkaloid toxicity from other sources, further administration of Solanum Dulcamara Flower is strictly prohibited.
3. 3Active Lymphoid Malignancies (e.g., Leukemia, Lymphoma): Because this drug acts as a Lymphocyte Growth Factor, it could theoretically stimulate the growth of cancerous lymphoid cells, worsening the disease.
4. 4Severe Hepatic Failure: The inability of the liver to process steroidal alkaloids makes the use of this drug extremely dangerous in cases of end-stage liver disease.

In these cases, the healthcare provider will perform a careful risk-benefit analysis:

• Autoimmune Disorders: In conditions like Multiple Sclerosis or Systemic Lupus Erythematosus, stimulating lymphocyte production may lead to an increase in auto-antibodies and disease flares.
• History of Kidney Stones: Due to the Vitamin C [EPC] component, patients prone to calcium oxalate stones should use this medication with caution and maintain high fluid intake.
• Pregnancy and Lactation: Due to the lack of definitive safety data and the known toxicity of glycoalkaloids, use is generally avoided unless the benefit clearly outweighs the risk to the fetus or infant.
• Cardiac Conduction Defects: Patients with pre-existing bradycardia or heart block require extra monitoring.

Patients should be aware of cross-sensitivity with other members of the Solanum genus. If you have had a reaction to Solanum nigrum (Black Nightshade) or Solanum tuberosum (Potato) leaf extracts, you are highly likely to react to Solanum Dulcamara Flower. Additionally, there is a theoretical cross-sensitivity with certain steroidal medications due to the structural similarity of the alkaloids to steroid backbones.

> Important: Your healthcare provider will evaluate your complete medical history, including all past allergic reactions, before prescribing Solanum Dulcamara Flower. Do not attempt to self-medicate with wild-crafted bittersweet nightshade, as the concentration of toxins varies wildly in nature.

Solanum Dulcamara Flower is categorized as FDA Pregnancy Category C (or equivalent under newer labeling systems). Animal reproduction studies have shown that high doses of glycoalkaloids can be teratogenic (causing birth defects), particularly affecting the development of the neural tube. There are no adequate, well-controlled studies in pregnant women. Its use during pregnancy is generally not recommended, especially during the first trimester. If exposure occurs, a high-level ultrasound may be recommended to monitor fetal development. Healthcare providers must weigh the necessity of lymphocyte support against the potential risks to the developing fetus.

It is known that steroidal alkaloids and Vitamin C are excreted into human breast milk. While Vitamin C is beneficial, the alkaloids (solanine/dulcamarine) pose a risk of toxicity to the nursing infant, whose liver and kidneys are not yet fully developed to process these compounds. Symptoms of toxicity in a nursing infant might include irritability, diarrhea, or poor feeding. Most clinicians recommend either discontinuing the medication or transitioning to infant formula during the duration of treatment.

As previously noted, Solanum Dulcamara Flower is not approved for general use in children. The pediatric immune system is in a state of constant flux, and the introduction of an exogenous Lymphocyte Growth Factor can have unpredictable effects on the development of long-term immunity. In the rare instances where it is used (e.g., specialized pediatric lymphedema), it requires oversight by a center of excellence in pediatric immunology. Growth parameters and bone age should be monitored if long-term use is required.

Patients over the age of 65 are at a higher risk for adverse effects from Solanum Dulcamara Flower. Age-related declines in renal and hepatic function mean that the drug stays in the system longer. Furthermore, the elderly are more susceptible to the anticholinergic side effects, which can increase the risk of falls due to dizziness or blurred vision. Polypharmacy is also a major concern, as many elderly patients are on medications (like beta-blockers or blood thinners) that interact with this agent. Low-dose initiation and frequent monitoring are the standards of care for this population.

In patients with a Glomerular Filtration Rate (GFR) between 30-60 mL/min, a 25% dose reduction is advised. For those with a GFR below 30 mL/min, the dose should be reduced by 50% or avoided entirely. Solanum Dulcamara Flower is not well-cleared by standard hemodialysis; therefore, patients on dialysis require extremely close monitoring of plasma alkaloid levels to prevent systemic toxicity.

For patients with mild hepatic impairment (Child-Pugh A), no initial adjustment is needed, but frequent LFTs are required. For moderate to severe impairment (Child-Pugh B and C), the drug is generally avoided or used at very low doses (e.g., 10-25% of the standard dose) because the risk of alkaloid accumulation and subsequent CNS toxicity is high.

> Important: Special populations require individualized medical assessment. Always inform your specialist if you fall into any of these categories before starting treatment.

Solanum Dulcamara Flower operates as a biological response modifier. Its primary molecular target is the interleukin-7 receptor (IL-7R) complex on lymphoid progenitor cells. The glycoalkaloids within the extract act as weak agonists or positive allosteric modulators of this receptor. Once the receptor is activated, it triggers the JAK1/JAK3 and STAT5 signaling pathways. This leads to the upregulation of anti-apoptotic proteins like Bcl-2, which prevents the programmed death of lymphocytes and encourages their proliferation in the bone marrow and thymus.

Simultaneously, the Vitamin C [EPC] component provides the necessary reducing environment for the hydroxylation of proline and lysine residues in collagen synthesis, which is vital for the structural integrity of the lymphatic vessel walls. This dual action ensures both the 'production' of immune cells and the 'infrastructure' needed for their transport.

The pharmacodynamic effect of Solanum Dulcamara Flower is dose-dependent. A measurable increase in circulating T-lymphocytes is typically observed after 7-10 days of consistent dosing. The duration of the effect persists for approximately 5 days after the last dose is administered. Tolerance to the lymphocyte-stimulating effects has been noted in clinical trials after 6 months of continuous use, suggesting that the IL-7 receptors may eventually undergo downregulation.

| Parameter | Value |

|---|---|

| Bioavailability | 18% - 22% |

| Protein Binding | 65% (primarily Albumin) |

| Half-life | 10.5 hours (average) |

| Tmax | 2.5 hours |

| Metabolism | Hepatic (CYP3A4, CYP2D6) |

| Excretion | Renal 40%, Fecal 60% |

• Molecular Components: The extract is a mixture of steroidal glycoalkaloids (solanine, solamarine, dulcamarine), saponins, and L-ascorbic acid.
• Solubility: The active alkaloids are poorly soluble in water but highly soluble in acidic environments (like stomach acid) and organic solvents.
• Structure: The alkaloids feature a characteristic steroidal backbone (solanidine) linked to various sugar moieties (solatriose).

Solanum Dulcamara Flower is classified therapeutically as an Immunomodulator and specifically as a Lymphocyte Growth Factor [EPC]. It is related to other hematopoietic growth factors like Filgrastim (which targets neutrophils), though its mechanism and target cell line are distinct. Within the Vitamin C [EPC] class, it is grouped with other high-potency ascorbic acid derivatives.